Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Cystectomy Outcomes
Cystectomy ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s cystectomy ACS NSQIP performance benchmarked against 113 participating sites.
| Cystectomy (113 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidityᵃ | 135 | 17.78% | 26.42% |
| Pneumonia | 135 | 0.74% | 2.26% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 135 | 6.67% | 4.95% |
| Urinary Tract Infection (UTI) | 135 | 0.74% | 3.40% |
| Surgical Site Infection (SSI)ᵃ | 135 | 5.19% | 13.66% |
| Sepsis | 135 | 5.19% | 8.65% |
| Unplanned Reoperation | 135 | 2.22% | 4.72% |
| Length of Stay | 105 | 17.14% | 17.04% |
| Unplanned Readmission | 135 | 23.70% | 24.36% |
| Anastomotic Leak | 135 | 0.74% | 2.27% |
| Prolonged NPO/NGT Use | 135 | 25.19% | 19.03% |
| Ureteral Obstruction | 135 | 1.48% | 4.55% |
| Urinary Leak/Fistulaᵃ | 135 | 0.00% | 5.12% |
| Lymphocele/Leak/Fluidᵃ | 135 | 0.00% | 5.45% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
